Charlotte A Gordon, Meike Graf, Colin D Hopley, Pete J Jennings, Melanie Littlewood
{"title":"启动全能DASH®与管式胰岛素泵治疗的时间:一项时间和运动研究。","authors":"Charlotte A Gordon, Meike Graf, Colin D Hopley, Pete J Jennings, Melanie Littlewood","doi":"10.1007/s13300-024-01686-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>There is currently a limited understanding of the process of initiating standard insulin pump therapy (IPT) and how this differs with pump type. A time-and-motion study was conducted in Germany and the United Kingdom (UK) to evaluate the time required for initiation with a tubeless insulin pump (a pod) versus other tubed pumps.</p><p><strong>Methods: </strong>The time taken to initiate patients onto tubeless IPT and tubed IPT (excluding automated insulin delivery systems, AID) was self-recorded by diabetes specialist nurses using a web-based tool. Pump users were adults with and without prior experience of IPT, and initiations were conducted face-to-face and remote.</p><p><strong>Results: </strong>In 276 recorded initiations (112 tubeless, 164 tubed, 89% type 1 diabetes), the mean time for initiating tubeless IPT was 13 min shorter compared with tubed IPT, 118 min [standard deviation (SD): 94] vs. 131 min [SD: 109]; p < 0.001. There was a particular benefit in people transferring from multiple daily injections (MDI) and for all initiations in a face-to-face setting. People transferring from MDI in a face-to-face setting had the highest time saving with tubeless IPT (24 min per nurse per initiation, p = 0.001), and this was also substantial for people in the face-to-face setting from both MDI and prior IPT (15 min per nurse per initiation, p = 0.002). According to survey responses, nurses reported initiations on tubeless IPT to be as effective as on tubed IPT despite taking less time.</p><p><strong>Conclusions: </strong>This novel time-and-motion study identified significant time reductions for initiating tubeless IPT vs. tubed IPT. Applying these time savings across pump services could increase efficiencies for initiating IPT and reduce workloads. Further time-and-motion studies for IPT and AID initiations are needed.</p>","PeriodicalId":11192,"journal":{"name":"Diabetes Therapy","volume":" ","pages":"629-644"},"PeriodicalIF":3.8000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925830/pdf/","citationCount":"0","resultStr":"{\"title\":\"Time to Initiation of Omnipod DASH® vs. Tubed Insulin Pump Therapy: A Time-and-Motion Study.\",\"authors\":\"Charlotte A Gordon, Meike Graf, Colin D Hopley, Pete J Jennings, Melanie Littlewood\",\"doi\":\"10.1007/s13300-024-01686-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>There is currently a limited understanding of the process of initiating standard insulin pump therapy (IPT) and how this differs with pump type. A time-and-motion study was conducted in Germany and the United Kingdom (UK) to evaluate the time required for initiation with a tubeless insulin pump (a pod) versus other tubed pumps.</p><p><strong>Methods: </strong>The time taken to initiate patients onto tubeless IPT and tubed IPT (excluding automated insulin delivery systems, AID) was self-recorded by diabetes specialist nurses using a web-based tool. Pump users were adults with and without prior experience of IPT, and initiations were conducted face-to-face and remote.</p><p><strong>Results: </strong>In 276 recorded initiations (112 tubeless, 164 tubed, 89% type 1 diabetes), the mean time for initiating tubeless IPT was 13 min shorter compared with tubed IPT, 118 min [standard deviation (SD): 94] vs. 131 min [SD: 109]; p < 0.001. There was a particular benefit in people transferring from multiple daily injections (MDI) and for all initiations in a face-to-face setting. People transferring from MDI in a face-to-face setting had the highest time saving with tubeless IPT (24 min per nurse per initiation, p = 0.001), and this was also substantial for people in the face-to-face setting from both MDI and prior IPT (15 min per nurse per initiation, p = 0.002). According to survey responses, nurses reported initiations on tubeless IPT to be as effective as on tubed IPT despite taking less time.</p><p><strong>Conclusions: </strong>This novel time-and-motion study identified significant time reductions for initiating tubeless IPT vs. tubed IPT. Applying these time savings across pump services could increase efficiencies for initiating IPT and reduce workloads. Further time-and-motion studies for IPT and AID initiations are needed.</p>\",\"PeriodicalId\":11192,\"journal\":{\"name\":\"Diabetes Therapy\",\"volume\":\" \",\"pages\":\"629-644\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925830/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s13300-024-01686-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13300-024-01686-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Time to Initiation of Omnipod DASH® vs. Tubed Insulin Pump Therapy: A Time-and-Motion Study.
Introduction: There is currently a limited understanding of the process of initiating standard insulin pump therapy (IPT) and how this differs with pump type. A time-and-motion study was conducted in Germany and the United Kingdom (UK) to evaluate the time required for initiation with a tubeless insulin pump (a pod) versus other tubed pumps.
Methods: The time taken to initiate patients onto tubeless IPT and tubed IPT (excluding automated insulin delivery systems, AID) was self-recorded by diabetes specialist nurses using a web-based tool. Pump users were adults with and without prior experience of IPT, and initiations were conducted face-to-face and remote.
Results: In 276 recorded initiations (112 tubeless, 164 tubed, 89% type 1 diabetes), the mean time for initiating tubeless IPT was 13 min shorter compared with tubed IPT, 118 min [standard deviation (SD): 94] vs. 131 min [SD: 109]; p < 0.001. There was a particular benefit in people transferring from multiple daily injections (MDI) and for all initiations in a face-to-face setting. People transferring from MDI in a face-to-face setting had the highest time saving with tubeless IPT (24 min per nurse per initiation, p = 0.001), and this was also substantial for people in the face-to-face setting from both MDI and prior IPT (15 min per nurse per initiation, p = 0.002). According to survey responses, nurses reported initiations on tubeless IPT to be as effective as on tubed IPT despite taking less time.
Conclusions: This novel time-and-motion study identified significant time reductions for initiating tubeless IPT vs. tubed IPT. Applying these time savings across pump services could increase efficiencies for initiating IPT and reduce workloads. Further time-and-motion studies for IPT and AID initiations are needed.
期刊介绍:
Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.
The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.